Related Experiment Video
Updated: Mar 26, 2026

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion
Haiying Wang1, Aihong Wang1, Zhenbo Hu1
1Department of Hematology, Affiliated Hospital of Weifang Medical University, Weifang, Shandong, China.
Abstract:
MicroRNAs are endogenous noncoding RNAs that play important roles in a wide variety of biologic processes such as apoptosis, development, aging, and tumorigenesis. The B-cell lymphoma 6 (BCL6) transcriptional repressor has emerged as a critical therapeutic target in diffuse large B-cell lymphomas (DLBCL), but the mechanisms regulating BCL6 are still unclear. In the current study, we screened the microRNA expression profiles in DLBCL specimens and cell lines by qRT-PCR and found that the expression of miR-144 was significantly downregulated in DLBCL tissues and cell lines and negatively correlated with BCL6 expression. We further demonstrated that BCL6 was the direct target gene of miR-144, and miR-144 suppressed the expression of BCL6 via binding the 3'untranslated region of BCL6 mRNA. Biologically, forced expression of miR-144 significantly attenuated cell proliferation and invasion of OCI-Ly3 cells in vitro, and the tumor-suppressor effect of miR-144 was also confirmed using a xenograft mouse model in vivo Taken together, our results reveal that miR-144 regulates BCL6 in DLBCL and provide a rationale for developing strategies that target miR-144 as a therapeutic intervention for DLBCL.
Insights
MicroRNA-144 (miR-144) is downregulated in diffuse large B-cell lymphoma (DLBCL) and suppresses tumor growth by targeting BCL6. Restoring miR-144 offers a potential therapeutic strategy for DLBCL patients.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs regulate crucial biological processes, including cancer development.
- The B-cell lymphoma 6 (BCL6) transcriptional repressor is a key therapeutic target in diffuse large B-cell lymphomas (DLBCL).
- Mechanisms controlling BCL6 expression in DLBCL remain incompletely understood.
Purpose of the Study:
- To investigate the role of microRNAs in regulating BCL6 expression in DLBCL.
- To identify specific microRNAs that are dysregulated in DLBCL and correlate with BCL6 levels.
- To evaluate the therapeutic potential of targeting identified microRNAs in DLBCL.
Main Methods:
- Screening of microRNA expression profiles in DLBCL tissues and cell lines using quantitative reverse transcription polymerase chain reaction (qRT-PCR).
- Validation of BCL6 as a direct target of miR-144 through analysis of 3' untranslated region (UTR) binding.
- In vitro experiments assessing the impact of miR-144 on DLBCL cell proliferation and invasion (OCI-Ly3 cells).
- In vivo studies using a xenograft mouse model to confirm the tumor-suppressor role of miR-144.
Main Results:
- miR-144 expression was significantly downregulated in DLBCL specimens and cell lines.
- A negative correlation was observed between miR-144 expression and BCL6 expression in DLBCL.
- BCL6 was identified as a direct target of miR-144, with miR-144 suppressing BCL6 via binding to its 3' UTR.
- Forced expression of miR-144 inhibited DLBCL cell proliferation and invasion in vitro.
- miR-144 demonstrated a tumor-suppressive effect in vivo using a xenograft mouse model.
Conclusions:
- miR-144 directly regulates BCL6 expression in DLBCL.
- Downregulation of miR-144 contributes to DLBCL pathogenesis.
- Targeting miR-144 represents a promising therapeutic strategy for DLBCL.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MicroRNAs

